Hedge Fund - Cormorant Asset Management
Get Email Alerts 13F Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
- 1 - 5
- Next >>
| No. | Security | Ticker | Shares | Value | Activity | % Port | History |
|---|---|---|---|---|---|---|---|
| 1. | Moonlake Immunotherapeutics | 8,494,151 | $512,961,779 | +5% | 24.49% | ||
| 2. | Ambrx Biopharma Inc | 11,231,000 | $159,929,440 | NEW | 7.63% | ||
| 3. | Eyepoint Pharmaceuticals Inc | 6,038,235 | $139,543,611 | +89% | 6.66% | ||
| 4. | BBIO | 3,344,179 | $135,004,506 | -29% | 6.44% | ||
| 5. | ACLX | 1,700,000 | $94,350,000 | -21% | 4.5% |
